Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-147288

Chief Legal Officer sold 3,912 shares at $21.83 ($85,399)

  • Chief Legal Officer acquired 3,912 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ali-Jackson Kamil Chief Legal Officer 2016-10-26 Option exercise +3,912 $1.52 $5,946 79,869 D
Ali-Jackson Kamil Chief Legal Officer 2016-10-26 Sale −3,912 $21.83 $85,399 75,957 D
Derivatives
Ali-Jackson Kamil Chief Legal Officer 2016-10-26 Option exercise · Employee StockOption (right to buy) −3,912 6,522 D
Open-market sales · 3,912 sh · avg $21.83 · $85,399
Loading xslF345X03/doc4.xml…